SLC2A2 and type 1 diabetes mellitus: Although it is not entirely specific to the pancreatic islet β-cells in vivo, AAb to Glut2 were previously reported in 77% of the new-onset T1DM patients screened, compared to a lack of anti-Glut2 antibody detection in 94% of non-diabetic control subjects49.